In summary, here we have highlighted a novel function of DTCD: sensitizing human ovarian cancer cells to TRAIL-induced apoptosis via upregulation of DR5 which is dependent on activation of the ASK1-ERK-Sp1 signaling pathway. The gene discussed is SP1; the disease is ovarian carcinoma.